Background: Comorbidity is an area of increasing interest in multiple sclerosis (MS).
Objective: The objective of this review is to estimate the incidence and prevalence of …

Among patients with multiple sclerosis (MS), fatigue is the most commonly reported
symptom, and one of the most debilitating. Despite its high prevalence and significant …

Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of the
central nervous system, characterized by the accumulation of numerous neurological …

Study Objectives: To report at a population level the prevalence of restless legs syndrome,
insomnia, and the risk of obstructive sleep apnea in multiple sclerosis patients. Sleep …

Background: Several studies have suggested that comorbid neurologic disorders are more
common than expected in multiple sclerosis (MS). Objective: To estimate the incidence and …

Background: Multiple sclerosis (MS), a subset of chronic primary inflammatory demyelinating
disorders of the central nervous system, is closely associated with various movement …

Patients with multiple sclerosis (MS) often have unrecognized sleep disorders at higher
frequency than the general population. Sleep disorders such as sleep disordered breathing …

Purposes Restless legs syndrome (RLS) is underdiagnosed and poorly understood by
clinicians and the general public alike; accordingly, a broad literature review with …

Although the interaction between comorbidities and chronic diseases is strong, the effect of
comorbidities receives little attention in many chronic diseases. In multiple sclerosis (MS), an …

Abstract Treatment of multiple sclerosis (MS)–related fatigue is still a challenging task, given
that no proven therapies exist and its mechanisms are not known. Our review highlights the …